TY - JOUR
T1 - Symptomatic and presumed symptomatic focal epilepsies in childhood: An observational, prospective multicentre study
AU - Vecchi, Marilena
AU - Barba, Carmen
AU - De Carlo, Debora
AU - Stivala, Micol
AU - Guerrini, Renzo
AU - Albamonte, Emilio
AU - Ranalli, Domiziana
AU - Battaglia, Domenica Immacolata
AU - Lunardi, Giada
AU - Boniver, Clementina
AU - Piccolo, Benedetta
AU - Pisani, Francesco
AU - Cantalupo, Gaetano
AU - Nieddu, Giuliana
AU - Casellato, Susanna
AU - Cappanera, Silvia
AU - Cesaroni, Elisabetta
AU - Zamponi, Nelia
AU - Serino, Domenico
AU - Fusco, Lucia
AU - Iodice, Alessandro
AU - Palestra, Filippo
AU - Giordano, Lucio
AU - Freri, Elena
AU - De Giorgi, Ilaria
AU - Ragona, Francesca
AU - Granata, Tiziana
AU - Fiocchi, Isabella
AU - Bova, Stefania Maria
AU - Mastrangelo, Massimo
AU - Verrotti, Alberto
AU - Matricardi, Sara
AU - Fontana, Elena
AU - Caputo, Davide
AU - Darra, Francesca
AU - Dalla Bernardina, Bernardo
AU - Beccaria, Francesca
AU - Capovilla, Giuseppe
AU - Baglietto, Maria Pia
AU - Gagliardi, Alessandra
AU - Vignoli, Aglaia
AU - Canevini, Maria Paola
AU - Perissinotto, Egle
AU - Francione, Stefano
PY - 2016
Y1 - 2016
N2 - Objective: To describe the clinical, neuropsychological, and psychopathologic features of a cohort of children with a new diagnosis of symptomatic or presumed symptomatic focal epilepsy at time of recruitment and through the first month. The selected population will be followed for 2–5 years after enrollment to investigate the epilepsy course and identify early predictors of drug resistance. Methods: In this observational, multicenter, nationwide study, children (age 1 month–12.9 years) with a new diagnosis of symptomatic or presumed symptomatic focal epilepsy were consecutively enrolled in 15 Italian tertiary childhood epilepsy centers. Inclusion criteria were as follows: (1) diagnosis of symptomatic focal epilepsy due to acquired and developmental etiologies, and presumed symptomatic focal epilepsy; (2) age at diagnosis older than 1 month and <13 years; and (3) written informed consent. Children were subdivided into three groups: ≤3 years, >3 to 6 years, and >6 years. Clinical, electroencephalography (EEG), neuroimaging, and neuropsychological variables were identified for statistical analyses. Results: Two hundred fifty-nine children were enrolled (116 female and 143 male). Median age: 4.4 years (range 1 month–12.9 years); 46.0% (n = 119) of children were younger than 3 years, 24% (61) from 3 to 6 years of age, and 30% (79) older than 6 years. Neurologic examination findings were normal in 71.8%. Brain magnetic resonance imaging (MRI) was abnormal in 59.9%. Children age ≤3 years experienced the highest seizure frequency in the first month after recruitment (p < 0.0001). Monotherapy in the first month was used in 67.2%. Cognitive tests at baseline revealed abnormal scores in 30%; behavioral problems were present in 21%. At multivariate analysis, higher chances to exhibit more than five seizures in the first month after epilepsy onset was confirmed for younger children and those with temporal lobe epilepsy. Significance: In this prospective cohort study, an extensive characterization of epilepsy onset in children with symptomatic or presumed symptomatic focal epilepsies is reported in relation to the age group and the localization of the epileptogenic zone.
AB - Objective: To describe the clinical, neuropsychological, and psychopathologic features of a cohort of children with a new diagnosis of symptomatic or presumed symptomatic focal epilepsy at time of recruitment and through the first month. The selected population will be followed for 2–5 years after enrollment to investigate the epilepsy course and identify early predictors of drug resistance. Methods: In this observational, multicenter, nationwide study, children (age 1 month–12.9 years) with a new diagnosis of symptomatic or presumed symptomatic focal epilepsy were consecutively enrolled in 15 Italian tertiary childhood epilepsy centers. Inclusion criteria were as follows: (1) diagnosis of symptomatic focal epilepsy due to acquired and developmental etiologies, and presumed symptomatic focal epilepsy; (2) age at diagnosis older than 1 month and <13 years; and (3) written informed consent. Children were subdivided into three groups: ≤3 years, >3 to 6 years, and >6 years. Clinical, electroencephalography (EEG), neuroimaging, and neuropsychological variables were identified for statistical analyses. Results: Two hundred fifty-nine children were enrolled (116 female and 143 male). Median age: 4.4 years (range 1 month–12.9 years); 46.0% (n = 119) of children were younger than 3 years, 24% (61) from 3 to 6 years of age, and 30% (79) older than 6 years. Neurologic examination findings were normal in 71.8%. Brain magnetic resonance imaging (MRI) was abnormal in 59.9%. Children age ≤3 years experienced the highest seizure frequency in the first month after recruitment (p < 0.0001). Monotherapy in the first month was used in 67.2%. Cognitive tests at baseline revealed abnormal scores in 30%; behavioral problems were present in 21%. At multivariate analysis, higher chances to exhibit more than five seizures in the first month after epilepsy onset was confirmed for younger children and those with temporal lobe epilepsy. Significance: In this prospective cohort study, an extensive characterization of epilepsy onset in children with symptomatic or presumed symptomatic focal epilepsies is reported in relation to the age group and the localization of the epileptogenic zone.
KW - Behavior impairment
KW - Childhood epilepsy
KW - Cognitive function
KW - Focal symptomatic seizures
KW - Intractable epilepsy
KW - Neurology
KW - Neurology (clinical)
KW - Behavior impairment
KW - Childhood epilepsy
KW - Cognitive function
KW - Focal symptomatic seizures
KW - Intractable epilepsy
KW - Neurology
KW - Neurology (clinical)
UR - http://hdl.handle.net/10807/95335
UR - http://www3.interscience.wiley.com/journal/117957420/issueyear?year=2009
U2 - 10.1111/epi.13574
DO - 10.1111/epi.13574
M3 - Article
SN - 0013-9580
VL - 57
SP - 1808
EP - 1816
JO - Epilepsia
JF - Epilepsia
ER -